
Table 1: Natural prevalence of NS3 protease-inhibitors associated RAVs detected by population sequencing
adapted from Sarrazin 2016 [19]
Table 1: Natural prevalence of NS3 protease-inhibitors associated RAVs detected by population sequencing
adapted from Sarrazin 2016 [19]